PHARMACEUTICAL COMPOSITION COMPRISING A LIPASE INHIBITOR AND A SUCROSE FATTY ACID ESTER

The present invention relates to a pharmaceutical composition comprising a lipase inhibitor, preferably orlistat, having a melting point 370C, a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable...

Full description

Saved in:
Bibliographic Details
Main Authors SCHEIBLER LUKAS CHRISTOPH, SCHROEDER MARCO, MEADER KARSTEN, MARTIN RAINER EUGEN, SCHINDLER THOMAS, RAAB SUSANNE
Format Patent
LanguageEnglish
Serbian
Published 27.10.2006
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a pharmaceutical composition comprising a lipase inhibitor, preferably orlistat, having a melting point 370C, a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients. Ovaj pronalazak se odnosi na farmaceutsku smešu koja sadrži inhibitor lipaze, prvenstveno orlistat, koji ima tačku topljenja ≥37°C, saharozni estar masne kiseline, pri čemu je ovaj saharozni estar masne kiseline mono-, di-, tri- ili tetra-estar, i opciono jedan ili više farmaceutski prihvatljivih ekscipijenata.
Bibliography:Application Number: YUP96003